Walleye Trading LLC Iovance Biotherapeutics, Inc. Transaction History

Walleye Trading LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $87,245 - $235,033	26,438 Added 522.9%	31,494 $256,000
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $22,448 - $44,442	5,056 New	5,056 $23,000
Q2 2022 Aug 08, 2022	BUY	$6.38 - $18.33 $157,611 - $452,824	24,704 New	24,704 $273,000
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $238,735 - $368,324	-19,284 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $30,038 - $50,148	1,815 Added 10.39%	19,284 $368,000
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $124,989 - $163,561	6,142 Added 54.22%	17,469 $431,000
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $161,487 - $327,029	9,889 Added 687.69%	11,327 $295,000
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $41,227 - $75,624	1,438 New	1,438 $46,000
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $283,637 - $427,384	-10,424 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $203,684 - $404,972	10,424 New	10,424 $312,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.24B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.